Cyp40 mRNA has also been reported to increase in

many breast cancer cell lines including MCF-7 [54]. Additionally, Cyp40 mRNA also increases in response to high temperature stress in MCF-7 cells [55]. Up-regulation of Cyp40 see more is reported to be correlated with oxidative stress in MCF-7 cells and prostate cancer cell lines. Genetic analysis of breast cancers shows 30% allelic loss of Cyp40 from patients heterozygous for Cyp40 [56]. Overexpression and potential roles for other Cyps in various cancer types are summarized in Table 2. Table 2 Other cyclophilins in human cancers Cancer type Isoforms Implications in cancers Contributers Breast cancer CypB A transcription inducer Fang et al., Am J Pathol. (2009). Breast cancer Cyp40 Having important functional implications for ER alpha and other

steroid receptors in breast cancer Eliseev etal., J Biol Chem. (2009)     Increasing in response to high temperature stress Machida etal., J Biol Chem. (2006) Breast cancer CypC Binding to osteopontin Forskolin chemical structure via CD147 and increase in migration and invasion Mi Z et al., Cancer Res. (2007) Tumors of the breast, ovary, and uterus CypD Inhibition of PT-pore Marzo et al., Cancer Res. (2007)     Interacton with Bcl2 Eliseev etal., J Biol Chem. (2009) Summary Cyps regulate protein folding through PPIase enzymatic and chaperone activities in specific locales of the cells to ensure correct conformation and to counterbalance conformational variations under diverse stress conditions. In addition to PPIase and chaperone activities, each isoform of Cyps has other specific intracellular and extracellular roles. Although roles of Cyps have recently

been explored in more details, many physiological and pathological aspects of Cyps’ biology still remain unclear. CypA among the Cyps was first reported to be upregulated in tumors, including small cell lung cancer, find more pancreatic cancer, breast cancer, colorectal cancer, squamous cell carcinoma, glioblastoma multiforme, and melanoma. This wide spectrum of cancers harboring excess CypA denotes an important role of Progesterone CypA in tumor development. The possible roles of CypA in cancers might involve increased cell proliferation, blockage of apoptosis, malignant transformation, angiogenesis, metastasis, and resistance to chemotherapeutic agents. Transcriptional upregulation of CypA mediated by p53 and HIF-1α during tumor development would magnify the cancer-prone effect of CypA. Some groups have proposed CypA as a cancer biomarker for certain cancer subtypes because expression levels nicely correlate with tumor progression. Although less informed at now, other Cyps are also known to be overexpressed and proposed to be involved in various cancers. CsA and SfA induce apoptosis in various cancer cells via inhibition of PPIase activity of Cyps, and have been tested for clinical applications in diverse cancer types [34]. However, CsA and Sfa can hardly be applied to cancer patients because of immunosuppressive effects.